Gene Therapy Research at St. Jude Children’s Hospital

Cancer Biology Program pic

St. Jude Children’s Research Hospital
Image: stjude.org

A clinical pharmacist, Dr. Ashkan Khabazian works in the emergency room of Sharp HealthCare in San Diego, where his responsibilities include reviewing microbiology results and assisting with antibiotic drug selection. Additionally, Dr. Ashkan Khabazian donates to organizations including St. Jude’s Hospital.

St. Jude Children’s Research Hospital works to save children’s lives by finding cures for cancer and other diseases. The hospital is currently developing new approaches to gene therapy, which entails replacing defective genes with healthy versions. Gene therapy is still undergoing research studies, but it’s becoming more frequent in clinical treatments for certain conditions.

Currently, better gene therapy vectors are being designed. St. Jude has made a substantial impact on vector development by creating vector designs for their patients with acute conditions, such as hemophilia and severe combined immunodeficiency. These vector designs have already begun to make a significant improvement in the lives of patients who participated in the clinical trials involving gene therapy for blood and immune disorders.

St. Jude Children’s Research Hospital Names New Director and VP

Cancer Biology Program pic

St. Jude Children’s Research Hospital
Image: stjude.org

As the clinical pharmacist for an emergency department, Ashkan Khabazian, PharmD, is responsible for administering medication based on patients’ emergency needs at Sharp HealthCare in San Diego, California. Outside of work, Dr. Ashkan Khabazian donates to St. Jude Children’s Research Hospital.

St. Jude Children’s Research Hospital is known for being a research hospital dedicated to helping children who have cancer. This includes both treatment for patients, and researching new ways to help young people who are battling the disease. In December of 2016, St. Jude named Ellis J. Neufeld, MD, PhD, as the new clinical director and executive vice president of the hospital.

Dr. Neufeld joins St. Jude as an experienced professional skilled in pediatric hematology. He has held the Egan Family Foundation Chair in Transitional Medicine while a professor of pediatrics at Harvard Medical School, and was the associate chief at the Boston Children’s Cancer and Blood Disorders Center. Dr. Neufeld also has previous experience working as a physician and scientist within a laboratory setting. His new role will begin in March of 2017.